CONR Conor Medsystems

MENLO PARK, Calif., June 8 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR) is scheduled to present at the Goldman Sachs 27th Annual Global Healthcare Conference on Tuesday, June 13, 2006 in Dana Point, Calif. Frank Litvack, M.D., Chairman and CEO, will provide a corporate update at 4:40 p.m. Pacific Time. To access the live audio broadcast or the subsequent archived recording, visit the webcast section of the company's website located at http://www.conormed.com/. The recording will be archived for 30 days following the live presentation. Please log on to Conor's website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary. About Conor Medsystems Conor Medsystems, Inc. develops innovative controlled vascular drug delivery technologies, and has initially focused on the development of drug-eluting stents to treat coronary artery disease. For further information on Conor Medsystems and controlled vascular delivery, visit http://www.conormed.com/. DATASOURCE: Conor Medsystems, Inc. CONTACT: investor inquiries, Michael Boennighausen, Chief Financial Officer of Conor Medsystems, Inc., +1-650-614-4100; or media, Karen L. Bergman of BCC Partners, +1-650-575-1509, for Conor Medsystems, Inc. Web site: http://www.conormed.com/

Copyright